Drawbacks of the use of cotrimoxazole in foreign-body infections

Cristina El Haj1, Alba Ribera1, Nuria Lloberas2

  • 1Laboratory of Experimental Infection, Infectious Diseases Service, IDIBELL-Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

Abstract

Insights

Cotrimoxazole shows reduced effectiveness against Staphylococcus aureus infections in foreign-body models due to high thymidine levels. This suggests reserving cotrimoxazole for later stages of infection treatment.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Cotrimoxazole efficacy is potentially reduced in difficult infections with high thymidine levels.
  • Foreign-body infections often involve significant pus and devitalized tissue, leading to high thymidine concentrations.

Purpose of the Study:

  • To evaluate cotrimoxazole activity against Staphylococcus aureus in an experimental foreign-body infection model.
  • To assess the impact of high thymidine levels on cotrimoxazole's anti-staphylococcal efficacy.

Main Methods:

  • Utilized a rat tissue-cage model of infection with methicillin-susceptible Staphylococcus aureus (MSSA).
  • Determined Minimum Inhibitory Concentration (MIC) values using a microdilution method.
  • Compared MICs in the presence and absence of tissue-cage fluid containing high thymidine levels.

Main Results:

  • Cotrimoxazole demonstrated inefficacy in the foreign-body infection model, similar to the control group.
  • The MIC of cotrimoxazole was 4-8 fold higher when tested in the presence of rat tissue-cage fluid.

Conclusions:

  • Cotrimoxazole's inefficacy in this MSSA foreign-body infection model highlights the negative impact of thymidine.
  • The findings challenge the use of cotrimoxazole during the acute phase of foreign-body infections.
  • Cotrimoxazole should be considered an alternative treatment option once the infection is better controlled.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
598
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
231
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
568
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
1.5K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K